Validation and quality control of protein microarray-based analytical methods
- PMID: 16156108
- DOI: 10.1385/1-59259-923-0:233
Validation and quality control of protein microarray-based analytical methods
Abstract
The microarray has emerged as an important format for simultaneous analysis of tens of thousands of substances present in a sample. Successful adaptation of microarray assays to clinical diagnostics will require particular attention to issues of quality control and quality assurance. Results of an assay can be compromised by a number of preanalytical factors including the quality of the reagents (e.g., the microarray and the detection reagents) and the integrity of the sample. Similarly, numerous factors in the analytical phase of a microarray assay, including changes in the reaction conditions and calibration, can contribute to inaccuracy and imprecision. Furthermore, a microarray combines many reagents or samples in a single device and therefore presents additional issues not usually encountered in discrete testing of a single analyte in a single sample. Various strategies (e.g., replicate analysis, array orientation control features, on-array controls, normalization) have been implemented to control and assess analytical factors that might compromise data generated from a microarray. The current range of measures taken to ensure the analytical accuracy and quality of data generated from protein microarrays is reviewed in the context of the lessons learned from DNA microarrays. The special considerations for protein microarrays as they transition from research into routine clinical analysis and the resulting quality control of clinical test results generated using such devices are discussed.
Similar articles
-
Diagnostic challenges for multiplexed protein microarrays.Drug Discov Today. 2006 Nov;11(21-22):1007-11. doi: 10.1016/j.drudis.2006.09.010. Epub 2006 Sep 26. Drug Discov Today. 2006. PMID: 17055410 Review.
-
Novel design and controls for focused DNA microarrays: applications in quality assurance/control and normalization for the Health Canada ToxArray.BMC Genomics. 2006 Oct 19;7:266. doi: 10.1186/1471-2164-7-266. BMC Genomics. 2006. PMID: 17052352 Free PMC article.
-
An alternative method to amplify RNA without loss of signal conservation for expression analysis with a proteinase DNA microarray in the ArrayTube format.BMC Genomics. 2006 Jun 12;7:144. doi: 10.1186/1471-2164-7-144. BMC Genomics. 2006. PMID: 16768788 Free PMC article.
-
Validation of peptide epitope microarray experiments and extraction of quality data.J Immunol Methods. 2007 Dec 1;328(1-2):1-13. doi: 10.1016/j.jim.2007.07.015. Epub 2007 Aug 13. J Immunol Methods. 2007. PMID: 17765917
-
Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies.Expert Rev Mol Diagn. 2007 Jan;7(1):87-98. doi: 10.1586/14737159.7.1.87. Expert Rev Mol Diagn. 2007. PMID: 17187487 Review.
Cited by
-
Miniaturized detection technology in molecular diagnostics.Expert Rev Mol Diagn. 2005 Jul;5(4):549-59. doi: 10.1586/14737159.5.4.549. Expert Rev Mol Diagn. 2005. PMID: 16013973 Free PMC article. Review.
-
Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.Proteome Sci. 2009 Apr 6;7:15. doi: 10.1186/1477-5956-7-15. Proteome Sci. 2009. PMID: 19348683 Free PMC article.